Allison London BrownAllison London BrownChief Executive Officer.

With extensive experience in product development, driving revenue and profitable growth in the Medical Device, Consumer, and Pharma industries, Allison London Brown is the CEO of Aegis Women’s Health, Inc. Allison comes to AWH with a diverse background in Women’s Healthcare, leading the Research, Clinical, Regulatory, Marketing, Communications and Sales efforts in the launch of over 80 new products and solutions.Prior to joining AWH, Allison served as the Chief Operating Officer of Stanley Healthcare Solutions, a division of Stanley Black&Decker, where she led a significant technology acquisition, and major organizational integration.Previously, she was at Healthways as the VP, Well-Being Strategy and Corporate Branding, successfully repositioning the company and actively supporting Healthways efforts throughout the Patient Protection and Affordable Care Act. She served as the General Manager of the Maternal Fetal Care division at GE Healthcare, working with global Ministries of Health, WHO, Gates Foundation and Clinton Foundation on “Safe Pregnancy” initiatives.

Allison has a broad background in Healthcare. She began her career as an Engineer with Johnson & Johnson Medical in Juarez, Mexico in 1997, and then transferred as a Global Researcher with Johnson & Johnson Consumer Care Products in R&D, Women’s Personal Care products. She transitioned into marketing, first as Marketing on Children’s Tylenol and Children’s Motrin, then Ethicon Women’s Health & Urology Global Marketing Manager and lastly as America’s Director, Sales and Marketing for Plastic Surgery and Dermabond.

Allison has a BS in Textile Science (Biomaterials) from Auburn University, a MS in Polymer Chemistry from North Carolina State University and a MBA in Strategic Management from the Fox School of Business at Temple University.

Allison published Chapter 7 of Bioactive Fibers and Polymers and has several patents. She is a presenter and author and has won many awards for her advertising and education programs on Women’s Health topics, physician and patient marketing.

She is a board member of Hollis Group and Scion Cardio-Vascular, both medical device start-ups, and has led product pipeline, strategy and fundraising initiatives for both organizations. She continues to support other start-ups and faith-based organizations on Commercialization and Marketing/Communication plans.

David BartonDavid BartonPresident

David Barton, MBA has rich experience in executive management, business development, sales, and marketing for both start ups and large organizations in the medical device and pharmaceutical arenas over the past 25 years. He has successfully brought to market both ethical and consumer medical products. Prior to joining Aegis Women’s Health, he served as President and VP Global Marketing/Business Development for Deep Breeze USA, an Israeli based non-invasive imaging start up. In that role, he led all sales, marketing, clinical research and reimbursement efforts in the US. At GE Healthcare he spearheaded the consummation of a variety of highly profitable strategic deals as Director of Business Development at GEHC’s $600M Life Support Solutions division. Previously he held VP Marketing/Sales positions at Baxter International, Solvay Pharmaceuticals, Akorn Ophthalmics, and Bristol Myers Squibb. At Bristol, he was very active in the women’s healthcare space, launching the Thin Prep Pap Test in co-ordination with Cytyx and the Mead Johnson complete line of prenatal vitamins.

Shantanu GaurShantanu GaurCo-Founder

Shantanu Gaur is an entrepreneur committed to developing novel solutions to unmet clinical needs. His background in chemical biology, materials science, and clinical medicine facilitates a multi-disciplinary approach to product development and product management. Shantanu graduated summa cum laude and Phi Beta Kappa from Harvard in 2008 with a degree in Biology. As a second-year medical student at Harvard Medical School, he co-founded Allurion Technologies with his classmate, Samuel Levy. At Allurion, Shantanu spearheaded the company’s product development, oversaw the pre-clinical benchtop, biocompatibility, and in vivo studies, and managed the company’s patent portfolio. He also co-led the development of numerous novel biomaterials including hydrogels, resorbables, thermoplastic elastomers, and medical textiles. Shantanu co-founded Aegis Women’s Health Technology in 2012 with Samuel Levy to tackle recurrent urinary tract infections—a clinical unmet need they often encountered as medical students—using their knowledge of biomaterials and polymer chemistry. He currently resides in Cambridge, MA.

Dr. Samuel LevyDr. Samuel LevyCo-Founder

Samuel Levy, MD is a medical device entrepreneur with a passion for developing simple technologies intended to address pressing unmet medical needs. In 2012, he co- founded Aegis Women’s Health Technology to combat recurrent urinary tract infections. To this effort, Samuel brings a strong background in clinical medicine, basic life science research, product development, project management, talent management and SME finance. Samuel began his career at McKinsey & Company in the firm’s New York office where he focused on pharmaceutical and medical products. Following his tenure at McKinsey, Samuel attended Harvard Medical School and during his second year, he co-founded Allurion Technologies with his classmate, Shantanu Gaur. They conceived an orally ingestible, satiety-inducing medical device for weight loss, built an intellectual property platform through patent authorship and licensing, and negotiated numerous product development deals. They also hired an experienced CEO, built a medical advisory board, raised several million dollars of private and non-dilutive capital, and recruited principal investigators for human clinical trials. Samuel has considerable experience leading the development of novel biomaterials including hydrogels, resorbables, thermoplastic elastomers, and medical textiles. He also has experience building a quality system and interacting with regulators. Samuel was a Fulbright Scholar to France and graduated summa cum laude and Phi Beta Kappa from Yale with a degree in Molecular Biophysics and Biochemistry. He lives in Paris, France with his wife Cynthia.